Medicine Man Technologies Inc Quick Ratio (MDCL) starting from the fourth quarter 2023 to fourth quarter 2022, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket
 


Medicine Man Technologies inc   (MDCL)
    Sector • Services    Industry • Consulting Services
   Industry • Consulting Services
   Sector • Services

Medicine Man Technologies Inc 's Quick Ratio

MDCL's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


In the wake of the increase in Current Liabilities in the fourth quarter 2023, Quick Ratio fell to 0.39 below Medicine Man Technologies Inc average.

Within Consulting Services industry 9 other companies have achieved higher Quick Ratio than Medicine Man Technologies Inc in fourth quarter 2023. While Quick Ratio total ranking has improved so far during the Q4 2023 to 2229, from total ranking in the third quarter 2023 at 3376.

Explain Quick Ratio?
How much Cash & cash equivalents MDCL´s has?
What are MDCL´s Current Liabilities?




MDCL Quick Ratio (Dec 31 2023)
Q4
(Sep 30 2023)
Q3
(Jun 30 2023)
Q2
(Mar 31 2023)
Q1
(Dec 31 2022)
Q4
Y / Y Current Liabilities Change 14.16 % 86.31 % 84.74 % -45.47 % -2.21 %
Y / Y Cash & cash equivalent Change -49.99 % -48.74 % -39.97 % -25.3 % -63.31 %
Quick Ratio MRQ 0.39 0.4 0.44 0.93 0.89
MDCL's Total Ranking # 2229 # 3376 # 1456 # 1950 #
Seq. Current Liabilities Change 0.27 % 10.17 % 19.36 % -13.42 % 63.64 %
Seq. Cash & cash equivalent Change -1.87 % -1.22 % -42.93 % -9.6 % 0.58 %



Quick Ratio fourth quarter 2023 Company Ranking
Within: No.
Consulting Services Industry # 10
Services Sector # 263
Overall Market # 2229


Quick Ratio Statistics
High Average Low
10.97 2.32 0.28
(Jun 30 2018)   (Dec 31 2018)




Financial Statements
Medicine Man Technologies Inc 's Current Liabilities $ 51 Millions Visit MDCL's Balance sheet
Medicine Man Technologies Inc 's Cash & cash equivalent $ 20 Millions Visit MDCL's Balance sheet
Source of MDCL's Sales Visit MDCL's Sales by Geography


Cumulative Medicine Man Technologies Inc 's Quick Ratio

MDCL's Quick Ratio for the trailling 12 Months

MDCL Quick Ratio

(Dec 31 2023)
12 Months
(Sep 30 2023)
12 Months
(Jun 30 2023)
12 Months
(Mar 31 2023)
12 Months
(Dec 31 2022)
12 Months
Y / Y Current Liabilities TTM Growth 11.21 % 6.8 % 0.74 % -5.73 % 94.75 %
Y / Y Cash & cash equivalent TTM Growth -40.21 % -49.4 % -35.98 % -24.99 % -7.26 %
Quick Ratio TTM 0.52 0.65 0.87 1.1 0.96
Total Ranking TTM # 3992 # 2494 # 3978 # 1650 #
Seq. Current Liabilities TTM Growth 3.51 % 15.03 % 15.61 % -19.21 % -0.6 %
Seq. Cash & cash equivalent TTM Growth -17.06 % -14.19 % -9.14 % -7.53 % -29.81 %


On the trailing twelve months basis Due to rise in Current Liabilities in the Q4 2023 to $50.53 millions, cumulative Quick Ratio decreased to 0.52 below the Medicine Man Technologies Inc average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Consulting Services industry 29 other companies have achieved higher Quick Ratio than Medicine Man Technologies Inc . While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the third quarter 2023 from 2494 to 3992.

Explain Quick Ratio?
How much Cash & cash equivalents MDCL´s has?
What are MDCL´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Consulting Services Industry # 30
Services Sector # 563
Within the Market # 3992


trailing twelve months Quick Ratio Statistics
High Average Low
1.65 1.04 0.59
(Sep 30 2019)   (Dec 31 2023)




Companies with similar Quick Ratio in the quarter ending Dec 31 2023, within Consulting Services Industry Quick RatioDec 31 2023 MRQ Cash & cash equivalentDec 31 2023 MRQ Current Liabilities
Mastech Digital Inc   1.06 $ 21.147  Millions$ 19.871  Millions
Wilhelmina International Inc   1.03 $ 12.713  Millions$ 12.330  Millions
Greenpro Capital Corp   0.97 $ 2.223  Millions$ 2.288  Millions
Ryvyl Inc   0.85 $ 73.318  Millions$ 86.070  Millions
Tss Inc   0.64 $ 11.831  Millions$ 18.420  Millions
Information Services Group Inc   0.59 $ 22.636  Millions$ 38.504  Millions
Genpact Limited  0.47 $ 583.670  Millions$ 1,248.397  Millions
Elvictor Group Inc   0.43 $ 0.699  Millions$ 1.622  Millions
Hackett Group Inc   0.42 $ 20.957  Millions$ 49.888  Millions
Medicine Man Technologies inc   0.39 $ 19.705  Millions$ 50.534  Millions
Ashford Inc   0.38 $ 52.054  Millions$ 135.404  Millions
Fti Consulting Inc  0.37 $ 303.222  Millions$ 824.832  Millions
Atif Holdings Ltd  0.32 $ 0.263  Millions$ 0.814  Millions
Cgi Inc   0.28 $ 857.947  Millions$ 3,101.089  Millions
Aeries Technology Inc   0.27 $ 6.543  Millions$ 24.001  Millions
Nordicus Partners Corporation  0.26 $ 0.007  Millions$ 0.027  Millions
Castellum Inc   0.23 $ 1.831  Millions$ 7.977  Millions
Booz Allen Hamilton Holding Corporation  0.22 $ 404.862  Millions$ 1,845.816  Millions
Onterris Inc   0.21 $ 23.240  Millions$ 112.368  Millions
Bowman Consulting Group Ltd   0.16 $ 20.687  Millions$ 126.756  Millions
Americann Inc  0.15 $ 0.808  Millions$ 5.223  Millions
1847 Holdings Llc  0.14 $ 5.749  Millions$ 40.176  Millions
Hapi Metaverse Inc   0.10 $ 0.746  Millions$ 7.683  Millions
Collective Audience Inc   0.09 $ 0.612  Millions$ 6.707  Millions
GenFlat Holdings, Inc.  0.08 $ 0.014  Millions$ 0.173  Millions

Date modified: 2026-09-08T15:11:13+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.